Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

Condition:   Glioblastoma Interventions:   Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF;   Drug: Temozolomide;   Biological: Tetanus-Diphtheria Toxoid (Td);   Biological: GM-CSF;   Biological: 111-Indium-labeling of Cells for in vivo Trafficking Studies Sponsor:   Gary Archer Ph.D. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials